Skip to main content
All lobbying filings

FAMILIES USA FOUNDATION, INC.

Lobbying for FAMILIES USA FOUNDATION INC

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$30,000
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

MediKids Act Continuous eligibility for kids Mama's First Act Medicaid coverage for doulas, midwives, and tribal midwives S.5269Pay PCPs Acta bill to task the Centers for Medicare & Medicaid Services (CMS) with establishing hybrid payments to reward primary care providers who provide the best care to their patients H.R. 9693Patients First ActLegislation to modify payments and incentive programs under the Medicare physician fee schedule. S.5089/HR9832Medicare Dental Benefit ActTo amend title XVIII of the Social Security Act to provide for coverage of dental services under the Medicare program. S.5091/HR9831Medicaid Dental Benefit Act A bill to amend title XIX of the Social Security Act to improve coverage of dental and oral health services for adults under Medicaid, and for other purposes.

S.527Prescription Pricing for the People Act of 2025To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes. S.1040Drug Competition Enhancement ActTo amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. S.1041Affordable Prescriptions for Patients ActTo amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1097Interagency Patent Coordination and Improvement Act of 2025To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. S.1095Stop STALLING ActTo enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. S.1096Preserve Access to Affordadable Generics and BiosimilarsTo prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products S.2276/3269ETHIC ActTo address patent thickets.

H.R. 7973Momnibus Act To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes. HR6248Healthy Competition for Better Care Actlegislation to ban anticompetitive terms in insurer-provider contracts S. 2355Patients Deserve Price Tags ActLegislation to strengthen and codify federal hospital and insurer transparency rules to ensure the publication of prices in dollars and cents Lower Costs, More Transparency ActLegislation to strengthen and codify federal hospital and insurer transparency rules to ensure the publication of prices in dollars and cents LIFT the BAR Act bill would restore access to critical public benefit programs for green card holders, DACA recipients, and other lawfully present immigrants

 Bills named in this filing 3
  • S. 5089
    Medicare Dental Benefit Act of 2026
  • S. 5091
    Medicaid Dental Benefit Act of 2026
  • S. 2276
    ETHIC Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem